Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4300 Bartlett St
Homer, AK 99603Phone+1 907-235-8101Fax+1 907-235-0877
Education & Training
- University of Utah HealthResidency, Family Medicine, 1979 - 1982
- University of Utah HealthInternship, Transitional Year, 1978 - 1979
- Indiana University School of MedicineClass of 1978
Certifications & Licensure
- AK State Medical License 1983 - 2024
- UT State Medical License 1979 - 2024
- WA State Medical License 1989 - 2019
- HI State Medical License 1988 - 2018
Awards, Honors, & Recognition
- Fellow (FACEP) American College of Emergency Physicians
Publications & Presentations
PubMed
- 76 citationsNanostructures of APOBEC3G Support a Hierarchical Assembly Model of High Molecular Mass Ribonucleoprotein Particles from Dimeric SubunitsJoseph E. Wedekind, Richard E. Gillilan, Alena Janda, Jolanta Krucinska, Jason D. Salter
The Journal of Biological Chemistry. 2006-12-15 - 251 citationsThe APOBEC Protein Family: United by Structure, Divergent in FunctionJason D. Salter, Ryan P. Bennett, Harold C. Smith
Trends in Biochemical Sciences. 2016-07-01 - 155 citationsFunctions and regulation of the APOBEC family of proteins.Harold C. Smith, Ryan P. Bennett, Ayse Kizilyer, William M. McDougall, Kimberly M. Prohaska
Seminars in Cell & Developmental Biology. 2012-05-01
Press Mentions
- AREV Engages Dr. Harold C. Smith to Join Scientific Advisory BoardJune 2nd, 2021
Grant Support
- Development Of A Novel HIV/AIDS Therapeutic Activating The APOBEC3G Host DefenseNational Institute Of Allergy And Infectious Diseases2011
- Development Of A High Throughput Screen For Antagonists Of Vif DimerizationNational Institute Of Neurological Disorders And Stroke2009–2011
- Based Deamination By CEM15 Suppresses HIV-1 InfectivityNational Institute Of Allergy And Infectious Diseases2004–2005
- The Role Of MRNA Editing In B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2004
- Role Of MRNA Editing In B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2003
- Metabolic Regulation Of Apolipoprotein B MRNA EditingNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2003
- Metabolic Regulation Of APO B MRNA EditingNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: